Advertisement
Canada markets open in 8 hours 5 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7327
    +0.0004 (+0.05%)
     

  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     

  • Bitcoin CAD

    87,728.71
    +124.27 (+0.14%)
     

  • CMC Crypto 200

    1,385.19
    +2.62 (+0.19%)
     

  • GOLD FUTURES

    2,348.50
    +6.00 (+0.26%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,761.25
    +193.75 (+1.10%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    38,051.88
    +423.40 (+1.13%)
     

  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Company News for Jun 11, 2021

Zacks Equity Research
·1 min read

  • Shares of Signet Jewelers Limited SIG jumped 14% after the company reported first-quarter fiscal 2022 earnings of $2.23 per share, beating the Zacks Consensus Estimate of $1.41.

  • Xinyuan Real Estate Co., Ltd.’s XIN shares surged 14% after the company highlighted completion of five newly constructed properties.

  • Shares of Verona Pharma plc VRNA jumped 13.2% after the company announced that it has entered into an agreement to develop and commercialize ensifentrine in Greater China with Nuance Pharma.

  • Pfizer Inc.’s PFE shares rose 2.2% after a news highlighted that the United States would pay the drugmaker about $3.5 billion for 500 million COVID-19 vaccine doses, to donate to the 100 lowest income countries.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer Inc. (PFE) : Free Stock Analysis Report
 
Signet Jewelers Limited (SIG) : Free Stock Analysis Report
 
Xinyuan Real Estate Co Ltd (XIN): Free Stock Analysis Report
 
Verona Pharma PLC American Depositary Share (VRNA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research